The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.

ABSTRACT:

SUBMITTER: Ball BJ 

PROVIDER: S-EPMC8335797 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature